Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
PAPs of three VISA isolates, one hetero-VISA isolate, and control... | Download Scientific Diagram
Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: a 14-year retrospective study | Antimicrobial Resistance & Infection
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant Staphylococcus aureus - Document - Gale Academic OneFile
Detection of Staphylococcus aureus with reduced susceptibility to vancomycin in a South African teaching hospital
Frontiers | IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus aureus Clinical Isolate
Lecture 4 Vancomycin resistance VRE VISA / hVISA / VRSA Thursday – 1/17/ ppt download
Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital
Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French h
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected b
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
![PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/306a583084d23ac2766f122cd384bf9952effebb/4-Figure2-1.png "PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar")
PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar
Aislamiento de Staphylococcus aureus hetero-resistente a vancomicina en Hospital Clínico Regional de Concepción, Chile
Acknowledgements References Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VIS
Le cauchemar des bactéries multirésistantes
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Frontiers | Rapid Detection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Based on Matrix-Assisted Laser Desorption Ionization Time-of-Flight: Using a Machine Learning Approach and Unbiased Validation
xmlinkhub
Drug Class Review Monograph – GPI Class 02 – Cephalosporins
Population analysis profile of VISA, hetero-VISA, and VSMRSA.... | Download Scientific Diagram
The First Vancomycin-Intermediate Staphylococcus aureus Strains Isolated from Patients in Thailand | Journal of Clinical Microbiology
Ceftaroline fosamil: drug profile and clinical data
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
KEGG PATHWAY: Nitrogen metabolism - Staphylococcus aureus subsp. aureus Mu3 (MRSA/hetero-VISA)
